Skip to main content
logo
Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.260
+0.050 (2.26%)
At close: Jun 12, 2026, 4:00 PM EDT
2.255
-0.005 (-0.22%)
Pre-market: Jun 15, 2026, 4:26 AM EDT

Alaunos Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-4.11-4.18-4.68-35.14-37.73-78.75
Depreciation & Amortization
0.020.0102.322.762.6
Stock-Based Compensation
0.40.410.442.83.5310.77
Other Adjustments
0.310.41-6.141.341.12
Change in Receivables
00-001.113.56
Changes in Accounts Payable
-0.430.1-0.1-0.77-0.030.27
Changes in Accrued Expenses
-0.040.02-1.16-3.99-0.67-10.51
Changes in Other Operating Activities
0.530.350.54-1.50.469.47
Operating Cash Flow
-3.13-2.87-4.97-30.14-29.23-61.47
Capital Expenditures
-0-0.1--0.2-0.22-3.32
Sale of Property, Plant & Equipment
---1.540.02-
Investing Cash Flow
-0-0.1-1.35-0.19-3.32
Long-Term Debt Issued
-----25
Long-Term Debt Repaid
----18.11-8.33-
Net Long-Term Debt Issued (Repaid)
----18.11-8.3325
Issuance of Common Stock
0.961.91-0.0914.751.04
Repurchase of Common Stock
-----0.05-
Net Common Stock Issued (Repurchased)
0.961.91-0.0914.71.04
Issuance of Preferred Stock
0.681.35----
Net Preferred Stock Issued (Repurchased)
0.681.35----
Other Financing Activities
----0.13--0.26
Financing Cash Flow
1.633.26--18.146.3725.78
Net Cash Flow
0.040.29-4.97-46.93-23.06-39.02
Free Cash Flow
-3.13-2.97-4.97-30.34-29.45-64.79
FCF Margin
-104300.00%-59340.00%-49710.00%-606780.00%-1007.80%-16279.10%
Free Cash Flow Per Share
-1.54-1.52-3.10-18.97-20.34-45.33
Levered Free Cash Flow
-4.03-3.8-5.4-57.38-43.76-55.24
Unlevered Free Cash Flow
-4.07-3.85-5.54-38.41-32.8-79.04
SEC Filings: 10-K · 10-Q